The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized controlled trials

The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized controlled trials

Dades bibliogràfiques
Autors principals:	Preiss, D, Armitage, J, Holman, R, Coleman, R, Spata, E
Format:	Journal article
Idioma:	English
Publicat:	American Diabetes Association 2021

Ítems similars

IDF21-0058 The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized trials
per: Preiss, D, et al.
Publicat: (2022)

Effect of fenofibrate on progression of diabetic retinopathy
per: Preiss, D, et al.
Publicat: (2024)

Comments on: Fenofibrate - a potential systemic treatment for diabetic retinopathy?
Publicat: (2012-06-01)

The Effectiveness and Safety of Fenofibrate and Saroglitazar in the Treatment of Diabetic Dyslipidemia
per: Bakhtawar Farooq, et al.
Publicat: (2024-05-01)

Association of Fenofibrate and Diabetic Retinopathy in Type 2 Diabetic Patients: A Population-Based Retrospective Cohort Study in Taiwan
per: Ying-Chieh Lin, et al.
Publicat: (2020-07-01)

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study.
per: Davis, T, et al.
Publicat: (2011)

Fenofibrate and statin therapy, compared with placebo and statin, slows the development of retinopathy in type 2 diabetes patients of 10 years duration: the ACCORD study.
per: Matthews, DR
Publicat: (2011)

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481].
per: Scott, R, et al.
Publicat: (2005)

Diabetic retinopathy and quality of life: a systematic review and Meta-analysis
per: Zayed, M, et al.
Publicat: (2024)

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials
per: Reith, C, et al.
Publicat: (2022)

Individual participant data meta-analysis of new-onset and worsening diabetes mellitus in large-scale randomized double-blind trials of statin therapy
per: Preiss, D, et al.
Publicat: (2022)

Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
per: Tonkin, A, et al.
Publicat: (2012)

Fenofibrate Therapy in Carnitine Palmitoyl Transferase Type 2 Deficiency
per: I. Hamilton-Craig, et al.
Publicat: (2012-01-01)

Cost-effectiveness of fenofibrate for preventing diabetic complications in Australia
per: Hansoo Kim, et al.
Publicat: (2024-11-01)

The need for a large-scale trial of fibrate therapy in diabetes: The rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]
per: Barter, P, et al.
Publicat: (2004)

Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate
per: Andrzej S. Januszewski, et al.
Publicat: (2024-11-01)

Quantifying early diabetic retinopathy.
per: Howard-Williams, JR, et al.
Publicat: (1986)

Larger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD Study
per: Simes, R, et al.
Publicat: (2009)

Insulin Independence in Newly Diagnosed Type 1 Diabetes Patient following Fenofibrate Treatment
per: Karsten Buschard, et al.
Publicat: (2020-01-01)

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
per: Keech, A, et al.
Publicat: (2005)

QiMing granules for diabetic retinopathy: a systematic review and meta-analysis of randomized controlled trials
per: Yazi Zhang, et al.
Publicat: (2024-08-01)

Pleiotropic effects of fenofibrate: focus on type 2 diabetes mellitus
per: Alexander Sergeevich Ametov, et al.
Publicat: (2014-12-01)

Cardiometabolic benefits of fenofibrate in heart failure related to obesity and diabetes
per: Jiwon Park, et al.
Publicat: (2024-09-01)

Effects of fenofibrate in patients with type 2 diabetes mellitus complicated by diabetic neuropathy
per: Olga Nikolaevna Tkacheva, et al.
Publicat: (2010-03-01)

Comment on Kim et al. The effect of a smartphone-based, patient-centered Diabetes care system in patients with type 2 Diabetes: a randomized, controlled trial for 24 weeks. Diabetes Care 2019;42:3-9.
per: Huo, X, et al.
Publicat: (2019)

Role of fenofibrate in multiple sclerosis
per: Ahmad A. Abulaban, et al.
Publicat: (2024-02-01)

Multiple testing correction in a meta-analysis of all adverse events recorded in large long-term randomised trials of statin therapy
per: Spata, E
Publicat: (2022)

Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis
per: Mark Simmonds, et al.
Publicat: (2024-12-01)

Effects of Fenofibrate on Adiponectin Expression in Retinas of Streptozotocin-Induced Diabetic Rats
per: Ying-Jung Hsu, et al.
Publicat: (2014-01-01)

Novel therapies for diabetic retinopathy
per: Magdalena Kupis, et al.
Publicat: (2022-01-01)

Randomised, multicentre, placebo-controlled trial of fenofibrate for treatment of diabetic macular oedema with economic evaluation (FORTE study): study protocol for a randomised control trial
per: Gerald Liew, et al.
Publicat: (2024-12-01)

Confined crystallization of fenofibrate in nanoporous silica
per: Dwyer, Leia Mary, et al.
Publicat: (2017)

Effect of fenofibrate on blood pressure reduction
Publicat: (2013-03-01)

Effect of fenofibrate on blood pressure reduction
Publicat: (2013-03-01)

Fenofibrate to prevent amputation and reduce vascular complications in patients with diabetes: FENO-PREVENT
per: Eu Jeong Ku, et al.
Publicat: (2024-09-01)

PROGRESSION OF DIABETIC-RETINOPATHY IN TYPE-2 DIABETIC-PATIENTS IN THE UK PROSPECTIVE DIABETES STUDY
per: Stratton, I, et al.
Publicat: (1993)

Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomised controlled trials
per: Goldie, C, et al.
Publicat: (2016)

Nine-year status of diabetic retinopathy and photocoagulation in the UK prospective diabetes study.
per: Aldington, S, et al.
Publicat: (1996)

Cell and molecular targeted therapies for diabetic retinopathy
per: Shivakumar K. Reddy, et al.
Publicat: (2024-06-01)

Update on the Treatment of Diabetic Retinopathy
per: Jennifer L. Wilkinson-Berka, et al.
Publicat: (2008-01-01)